$6.9m follower assets
Lars Fruergaard Jørgensen CEO of Novo Nordisk $NVO ('In Good Company' - Nicolai Tangen)
In the latest episode of 'In Good Company', Nicolai Tangen speaks to the CEO of Novo Nordisk $NVO, Lars Fruergaard Jørgensen. They discuss various topics around:
- How obesity impacts people's life
- Lars's concerns about lack of access for most people to some of the new medicines
- The importance of purpose and Novo Nordisk $NVO new weight loss drug
Tagging @ifb_podcast who might be interested into the conversation, in particular.
Source: FirstWord Pharma
I think @chandler_s and @stockopine may really enjoy this episode too
Author
Related
Already have an account?